Glp 2t For Sale: Analytical Standards & Sourcing Overview
High-purity GLP-2T is an engineered glucagon-like peptide-2 analog utilized extensively in preclinical assays evaluating enteric epithelial proliferation, mucosal repair, and nutrient transport kinetics. PX1 Research provides verified, laboratory-grade GLP-2T for sale strictly dedicated to in vitro and preclinical research applications, backed by full lot-specific analytical verification.
Quick answer
High-purity GLP-2T is an engineered glucagon-like peptide-2 analog utilized extensively in preclinical assays evaluating enteric epithelial proliferation, mucosal repair, and nutrient transport kinetics. PX1 Research provides verified, laboratory-grade GLP-2T for sale strictly dedicated to in vitro and preclinical research applications, backed by full lot-specific analytical verification.
Key takeaways
- Researchers seeking high-purity GLP 2T for sale can obtain verified laboratory-grade peptide reagents directly through PX1 Research.
- Glucagon-like peptide-2 (GLP-2) is a 33-amino acid peptide derived from the post-translational processing of proglucagon in enteroendocrine L-cells.
- In preclinical model systems, GLP-2T serves as a key probe for investigating gastroenterological histology and barrier function.
- Understanding where GLP-2T fits within the broader landscape of regulatory peptides requires contrasting its target specificity with metabolic and cytoprotective analogues studied in experimental physiology.
Sourcing GLP-2T For Sale: Direct Procurement & Overview
Researchers seeking high-purity GLP 2T for sale can obtain verified laboratory-grade peptide reagents directly through PX1 Research. Formulated strictly for in vitro assays and preclinical models, GLP-2T features lot-specific RP-HPLC and mass spectrometry verification to guarantee >99% sequence integrity, zero filler, and ultra-low endotoxin levels (<0.01 EU/mg) for reproducible enteric signaling experiments.
When evaluating vendors offering research peptides for sale, laboratory managers must prioritize chemical purity and rigorous quality control over unverified low-cost reagents. Inconsistent peptide synthesis, residual trifluoroacetic acid (TFA), or bacterial endotoxin contamination can confound in vitro cell culture assays and distort physiological data in animal models. PX1 Research provides transparent chemical analytical data with every order, ensuring research institutions receive fully characterized reagents manufactured in compliant domestic facilities.
Molecular Architecture and Structural Biochemistry of GLP-2T
Glucagon-like peptide-2 (GLP-2) is a 33-amino acid peptide derived from the post-translational processing of proglucagon in enteroendocrine L-cells. Endogenous GLP-2 exhibits an extremely short biological half-life in physiological systems (typically 7 to 7 minutes) due to rapid enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV) at the alanine residue at position 2 (Ala2). GLP-2T is a chemically modified, DPP-IV-resistant analog of GLP-2, featuring an amino acid substitution—typically substitution of alanine at position 2 with glycine ([Gly2]GLP-2)—that blocks N-terminal cleavage.
This targeted amino acid modification significantly enhances the metabolic stability of the peptide in biological matrices while preserving its binding affinity for the glucagon-like peptide-2 receptor (GLP-2R). In structural modeling and ligand-receptor docking studies, GLP-2T retains full agonist selectivity for the G-protein coupled GLP-2R, triggering intracellular cyclic AMP (cAMP) accumulation and activating downstream intracellular signaling cascades without susceptible enzymatic degradation.
Preclinical Research Pathways: Enteric Mucosal Dynamics
In preclinical model systems, GLP-2T serves as a key probe for investigating gastroenterological histology and barrier function. Animal study literature indicates that GLP-2R activation modulates crypt cell proliferation and inhibits enterocyte apoptosis in the small and large intestine. Research designs utilizing GLP-2T frequently evaluate intestinal wet weight, villus height, crypt depth, and total mucosal protein density following administration in rodent models.
Furthermore, in vitro research on mucosal monolayer cell lines (such as Caco-2 monolayers) indicates that GLP-2 signaling pathways influence the expression of tight junction proteins, including occludin, claudin-1, and zonula occludens-1 (ZO-1). By upregulating these structural components, GLP-2 receptor agonists decrease paracellular permeability across mucosal membranes. Researchers analyzing gut-barrier failure, nutrient malabsorption, or intestinal ischemia-reperfusion models routinely utilize GLP-2 research compounds to map these microvascular and epithelial responses.
Comparative Analysis: GLP-2T vs. Related Gastrointestinal & Metabolic Peptides
Understanding where GLP-2T fits within the broader landscape of regulatory peptides requires contrasting its target specificity with metabolic and cytoprotective analogues studied in experimental physiology. While both GLP-1 and GLP-2 originate from the proglucagon gene, their tissue distribution and primary signaling outcomes diverge substantially.
Metabolic research probes such as Semaglutide and dual-agonist compounds like Tirzepatide focus primarily on GLP-1 and GIP receptors to regulate pancreatic insulin secretion, gastric emptying rates, and central appetite signaling. In contrast, GLP-2T acts selectively on GLP-2R expressed predominantly on enteric neurons, subepithelial myofibroblasts, and enteroendocrine cells. Unlike metabolic agents, GLP-2T does not directly modulate systemic glycemic control or pancreatic hormone release. When mucosal protection or non-gastroincretin tissue repair is investigated, researchers often compare GLP-2T alongside repair-focused compounds like BPC-157 or anti-inflammatory fragments like KPV to differentiate local signaling cascades from receptor-mediated trophic responses.
Reconstitution and Laboratory Handling Guidelines
Proper reconstitution technique is essential for maintaining peptide conformational stability and preventing aggregate formation. Lyophilized GLP-2T should be reconstituted under sterile conditions using appropriate laboratory solvents. Standard protocols utilize sterile bacteriostatic water or sterile 0.9% sodium chloride injection solution, depending on downstream assay compatibility.
To reconstitute GLP-2T for laboratory use, allow the vial to equilibrate to room temperature (18°C to 25°C) before introducing the diluent. Inject the solvent down the inner glass wall of the vial rather than directly onto the lyophilized cake. Gently swirl the vial in a circular motion until complete dissolution is observed; mechanical agitation, vigorous shaking, or vortexing must be strictly avoided, as shear forces can cause peptide denaturation or aggregation. For experiments requiring ultra-low salt concentration, micro-titration with dilute acetic acid (0.1%) may be employed to facilitate solubilization prior to dilution in physiological buffers.
Lyophilization Stability and Temperature Storage Parameters
In its original, desiccated lyophilized form, GLP-2T maintains chemical stability over extended durations when stored at -20°C or -80°C in a moisture-controlled environment. Upon receipt, lyophilized vials should be protected from light exposure to prevent photo-oxidation of sensitive amino acid residues, particularly tryptophan or histidine residues present in the peptide chain.
Once reconstituted into aqueous solution, GLP-2T displays increased susceptibility to hydrolysis and oxidation. Working aliquots should be prepared immediately following reconstitution to avoid repeated freeze-thaw cycles, which degrade peptide purity. Solubilized aliquots kept at 2°C to 8°C should be utilized within short windows (typically 7 to 14 days), while long-term liquid storage requires freezing at -80°C. Further analytical protocols and storage considerations can be reviewed in the PX1 peptides research hub.
Analytical Quality Control: RP-HPLC, Mass Spectrometry, and Endotoxin Testing
To ensure reproducible experimental outcomes, every lot of GLP-2T for sale through PX1 Research undergoes multi-point analytical verification by independent, ISO 17025-accredited testing laboratories. High-Performance Liquid Chromatography (RP-HPLC) is utilized to measure chemical purity, verifying that the target sequence accounts for >99% of total UV-absorbing species in the sample.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass of the peptide, verifying sequence identity against expected theoretical calculations. In addition, mandatory Limulus Amebocyte Lysate (LAL) testing guarantees endotoxin thresholds below 0.01 EU/mg. Endotoxin contamination is a primary source of batch-to-batch variance in cell culture and animal models; guaranteeing low EU levels prevents false-positive inflammatory responses in sensitive preclinical assays.
Procurement for Academic & Institutional Research Facilities
PX1 Research maintains a secure, streamlined supply chain specifically tailored for academic universities, contract research organizations (CROs), and private biotechnology facilities. All research reagents are synthesized in domestic, GMP-compliant facilities within the United States, eliminating customs bottlenecks and international shipping degradation.
Orders are dispatched with same-day shipping (Monday through Friday) from centralized distribution centers located in California and Arizona. Each shipment includes full lot-matched Certificates of Analysis (COAs) downloadable directly from our portal. For large-scale studies, high-throughput screening, or bulk laboratory acquisitions, investigators can establish institutional pricing via our dedicated wholesale procurement platform.
Frequently Asked Questions
What is GLP-2T studied for in preclinical research?
GLP-2T is studied in preclinical research as a DPP-IV-resistant analog of glucagon-like peptide-2. Researchers investigate its role in enteric crypt cell proliferation, mucosal barrier repair, tight junction expression, and nutrient absorption kinetics in cell culture and rodent models.
How does GLP-2T differ from standard native GLP-2?
Native GLP-2 is rapidly degraded in vivo and in biological matrices by the enzyme dipeptidyl peptidase-IV (DPP-IV) at position 2 (Ala2). GLP-2T incorporates an amino acid substitution (such as Gly2) that resists enzymatic degradation, markedly increasing its half-life in experimental protocols.
What purity levels are guaranteed when purchasing GLP-2T from PX1 Research?
Every lot of GLP-2T supplied by PX1 Research is verified via RP-HPLC to meet or exceed 99% chemical purity. Identity is confirmed via mass spectrometry (ESI-MS), and lot-specific COAs are provided with each order.
What are the endotoxin limits for PX1 Research GLP-2T?
PX1 Research enforces strict endotoxin screening via LAL testing, ensuring endotoxin levels remain under 0.01 EU/mg. This prevents unwanted immune cell activation or artifactual data in sensitive cellular assays.
How should lyophilized GLP-2T be stored upon arrival?
Lyophilized GLP-2T should be stored at -20°C or -80°C in a desiccated container away from direct light. Under these conditions, the peptide remains stable for extended laboratory storage.
What solvent is recommended for reconstituting GLP-2T?
Standard laboratory protocols utilize sterile bacteriostatic water or sterile physiological saline. If dissolution challenges occur, micro-titration with dilute (0.1%) acetic acid can assist before diluting to target working concentrations in buffer.
Does GLP-2T interact with GLP-1 receptors?
In vitro binding studies indicate GLP-2T possesses high selective affinity for the GLP-2 receptor with negligible cross-reactivity at the GLP-1 receptor at physiological concentrations.
Is GLP-2T approved for human administration or clinical use?
No. GLP-2T supplied by PX1 Research is strictly sold as a research compound for in vitro, cell culture, and preclinical animal models. It is not intended for human or veterinary medical use, clinical trials, or therapeutic applications.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.